Robb, Catherine
Carr, Prudence R.
Ball, Jocasta
Owen, Alice
Beilin, Lawrence J.
Newman, Anne B.
Nelson, Mark R.
Reid, Christopher M.
Orchard, Suzanne G.
Neumann, Johannes T.
Tonkin, Andrew M.
Wolfe, Rory
McNeil, John J.
Funding for this research was provided by:
National Health and Medical Research Council (IG 1173690, 334047, 334047, 334047, IG 1173690)
National Institute on Aging (U01AG029824, U01AG029824, U01AG029824)
National Institutes of Health (U19AG062682, U19AG062682, U19AG062682)
Article History
Received: 2 February 2023
Accepted: 20 August 2023
First Online: 11 October 2023
Declarations
:
: In Australia ethics approvals were obtained from the Monash University Human Research Ethics Committee, RACGP Ethics Committee, University of Tasmania Ethics Committee, Australian National University Human Research Ethics Committee, ACT Health Human Research Ethics Committee, and the University of Adelaide Ethics Committee. Informed consent was obtained from all the participants. All methods were carried out in accordance with the Declaration of Helsinki.
: Not applicable.
: A.M.T has received honoraria from Amgen, Boehinger-Ingelheim, Merck, Novartis and Pfizer. M.R.N served on a Novartis lipids advisory board. All other authors have no conflicts of interest.